Ellipsis Health Secures $26 Million in Series A Funding To Pioneer New Voice Biomarker As A Clinical Standard In Mental Health Care

Ellipsis Health raised $26 million in Series A funding to further its measurement-based approach to using voice analysis to identify and quantify behavioral health conditions. With the funding, Ellipsis Health will continue to grow its customer base, expand global partnerships, build a multidisciplinary team, research, and develop new voice-based technology for detecting behavioral health disorders. The company intends to focus on expanding its voice vital sign to address the mental health of children and adolescents.

Ellipsis’ models analyze both what is said (using natural language processing) and how it is said (acoustics, such as tone and timing) to . . .